2Collins FS, Varmus H. A new initiative on precision medicine [J]. N Engl J Med, 2015, 372(9): 793-795. DOI: 10. 1056/ NEJMp1500523.
3Sultan M, Schulz MH, Richard H, et al. A global view of gene activity and alternative splicing by deep sequencing of the human transcriptome[J]. Science, 2008, 321(5891): 956-960. DOI: 10. 1126/science. 1160342.
5Zong C, Lu S, Chapman AR, et al. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell[J]. Science, 2012, 338(6114): 1622-1626. DOI:10. l126/science. 1229164.
6Wang Y, Waters J, Leung ML, et al. Clonal evolution in breast cancer revealed by single nucleus genome sequencing[J]. Nature, 2014, 512(7513): 155-160. DOI: 10. 1038/ nature 13600.
7Naert K, Habeed AA, Gedye C, et al. Targeted therapy in melanoma: the era of personalized medicine[J]. Diagnostic Histopathology, 2014, 20(11): 425-430. DOI: 10. 1016/j. mpdhp. 2014. 10. 001.
8Kakavand H, Wilmott JS, Long GV, et al. Targeted therapies and immune checkpoint inhibitors in the treatment of metastatic melanoma patients: a guide and update for pathologists[J]. Pathology, 2016, 48(2): 194-202. DOI: 10. 1016/j. pathol. 2015.12. 010.
9Fleming KA. Pathology and cancer policy[J]. Journal of Cancer Policy. 2016, 7: 32-35. DOI: 10. 1016/j. jcpo. 2015. 12. 005.
10Saho-Tellez M, James JA, Hamilton PW. Molecular pathology: the value of an integrative approach[J]. Mol Oncol, 2014, 8(7): 1163-1168. DOI: 10. 1016/j. molonc. 2014.07. 021.
